A group of inheritors takes charge with new ideas and new strategies.
India’s venerated $37 billion pharma industry is at the crossroads. The road to new drug discovery – after decades of disappointing results – is famously pot-holed and, with half-discoveries being touted as new drugs, appears to be leading nowhere; The road to money-spinners such as Para-IV exclusivity, generic-generics and branded generics is facing rapid speed-breakers of competition, commoditisation and price erosion. In the interim, domestic pharma majors went on the road to tactical M&As to foster growth. But the most promising road is the way to complex generics, specialty drugs and bio-similars. It is also the most arduous, requiring a decoction of cutting-edge science, speed and agility and outstanding selling prowess – neither of which is Indian pharma majors’ strength.
That calls for reassessing the ground realities and implementation of new strategies, fresh thinking and, most importantly, fresh blood. Just as the doctor ordered, the scions – some second generation and some third – of Indian pharma majors are readying to take on this onerous responsibility.
This is a watershed moment. If they succeed, India will still have a home-grown pharmaceutical industry. If they don’t, the domestic pharma landscape will be peppered with foreign-owned Indian pharma companies, a trend that has accelerated since the beginning of this decade.
この記事は Business Today の May 21, 2017 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です ? サインイン
この記事は Business Today の May 21, 2017 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です? サインイン
Pension Scheme - Safety Net
The move to introduce the UPS has evoked mixed reactions. Analysts believe its funding will have limited impact on the fiscal math
The Reit Choice?
Real Estate Investment Trusts (Reits) Are Gaining Traction As Interest Rates Stabilise. But Returns Could Be Affected By Adverse Economic Conditions And Market Volatility
CORPORATE - Calling to Account
The sudden exit of Byju's auditor BDO marks the latest in a long series of setbacks for the edtech firm
EMPLOYMENT: Skills Push
The skill development ministry plans to partner with the UGC to improve the employability of undergraduates
Building on a Vision
L&T'S CHAIRMAN EMERITUS A. M. NAIK HAS BUILT A MAMMOTH ENTERPRISE THAT IS BUILDING A NEW INDIA, FROM ITS METRO RAIL SYSTEMS TO THE RAM TEMPLE
"KYS more important than KYC"
Vijay Kedia is a renowned equity investor; the value of his listed portfolio stands at around ₹1,750 crore
ROXX STAR
THE THAR ROXX COMBINES LUXURY WITH PERFORMANCE TO MAKE A STRONG STATEMENT IN THE MID-SIZE SUV SEGMENT
HIT THE GROUND RUNNING
Smartwatches have become indispensable tools for runners, offering real-time insights into pace, distance, heart rate, and more. Here are a few you can consider
TURNING THE TABLES
INDIA'S FURNITURE MARKET IS POISED FOR A GLOBAL TAKE-OFF. ALREADY, A HOST OF GLOBAL BRANDS HAVE MADE THE COUNTRY THEIR HOME, BUT INDIAN COMPANIES ARE NOT TOO FAR BEHIND
THE EVOLUTION OF ATHERA
IDENTIFYING OPPORTUNITIES IN ADVANCE HAS STOOD THIS BENGALURU-BASED VC FUND IN GOOD STEAD. NOW, WITH A HEIGHTENED FOCUS ON TECHNOLOGY, IT WANTS TO SUSTAIN THE SUCCESS